The role of mitochondrial dysfunction in psychiatric disease

Developmental Disabilities Research Reviews

Volumn 16, Issue 2, 2010, Pages 136-143

  Scaglia, Fernando ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Bipolar disorder; Major depressive disorder; Mitochondrial dysfunction; Psychiatric disease; Schizophrenia

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA;

BIPOLAR DISORDER; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DEMENTIA; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA POLYMORPHISM; ELECTRON TRANSPORT; ENERGY METABOLISM; GENE DELETION; GENE EXPRESSION; HUMAN; LANGUAGE ABILITY; LEIGH DISEASE; MAJOR DEPRESSION; MELAS SYNDROME; MEMORY DISORDER; MENTAL DISEASE; MITOCHONDRIAL ENCEPHALOMYOPATHY; NEUROIMAGING; NEUROLOGIC DISEASE; NONHUMAN; PERCEPTION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77956236965     PISSN: 19405510     EISSN: 10982779     Source Type: Journal    
DOI: 10.1002/ddrr.115     Document Type: Review

References (100)

1. Al-Mousawi AH, Evans N, et al. 1996. Limbic dysfunction in schizophrenia and mania. A study using 18F-labelled fluorodeoxyglucose and positron emission tomography. Br J Psychiatry 169:509-516. (Pubitemid 126735808)
2. Altar CA, Jurata LW, et al. 2005. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 58:85-96.
3. Amemiya S, Hamamoto M, et al. 2000. Psychosis and progressing dementia: presenting features of a mitochondriopathy. Neurology 55:600-601.
4. Belmaker RH. 2004. Bipolar disorder. N Engl J Med 351:476-486.
5. Bolanos JP, Medina JM. 1997. Effect of valproate on the metabolism of the central nervous system. Life Sci 60:1933-1942.
6. Brenner-Lavie H, Klein E, et al. 2008. Dopamine modulates mitochondrial function in viable SH-SY5Y cells possibly via its interaction with complex. I. Relevance to dopamine pathology in schizophrenia. Biochim Biophys Acta 1777:173-185.
7. Buchsbaum MS, Hazlett EA. 1998. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull 24:343-364. (Pubitemid 28378221)
8. Carlsson A, Waters N, et al. 1999. Neurotransmitter interactions in schizophrenia - therapeutic implications. Biol Psychiatry 46:1388-1395.
9. Cavelier L, Jazin EE, et al. 1995. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics 29:217-224.
10. Cui J, Shao L, et al. 2007. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 144:1447-1453. (Pubitemid 46123817)
11. Deicken RF, Weiner MW, et al. 1995. Decreased temporal lobe phosphomonoesters in bipolar disorder. J Affect Disord 33:195-199.
12. Einat H, Yuan P, et al. 2005. Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: further support for the involvement of mitochondrial function in anxiety disorders. Behav Brain Res 165:172-180.
13. Fanous AH, Kendler KS. 2005. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol Psychiatry 10:6-13.
14. Fattal O, Budur K, et al. 2006. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 47:1-7. (Pubitemid 43017115)
15. Fujimoto T, Nakano T, et al. 1992. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging. Acta Psychiatr Scand 86:455-462.
16. Goldstein JM, Faraone SV, et al. 1990. Sex differences in the familial transmission of schizophrenia. Br J Psychiatry 156:819-826.
17. Grigoroiu-Serbanescu M, Martinez M, et al. 1998. Patterns of parental transmission and familial aggregation models in bipolar affective disorder. Am J Med Genet 81:397-404.
18. Grover S, Padhy SK, et al. 2006. Mania as a first presentation in mitochondrial myopathy. Psychiatry Clin Neurosci 60:774-775.
19. Hahn CG, Friedman E. 1999. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disord 1:81-86.
20. Hamakawa H, Kato T, et al. 1999. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychol Med 29:639-644. (Pubitemid 29261352)
21. Hamakawa H, Murashita J, et al. 2004. Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin Neurosci 58:82-88.
22. Inuwa IM, Peet M, et al. 2005. QSAR modeling and transmission electron microscopy stereology of altered mitochondrial ultrastructure of white blood cells in patients diagnosed as schizophrenic and treated with antipsychotic drugs. Biotech Histochem 80:133-137.
23. Iwamoto K, Bundo M, et al. 2005. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 14:241-253.
24. Jaksch M, Lochmuller H, et al. 2001. A mutation in mt tRNALeu(UUR) causing a neuropsychiatric syndrome with depression and cataract. Neurology 57:1930-1931. (Pubitemid 33096717)
25. Jarskog LF, Gilmore JH, et al. 2000. Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia. Biol Psychiatry 48:641-650.
26. Kakiuchi C, Ishiwata M, et al. 2005. Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia. Int J Neuropsychopharmacol 8:515-522.
27. Kasahara T, Kubota M, et al. 2006. Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Mol Psychiatry 11:577-593, 523.
28. Kato T, Kato N. 2000. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2:180-90.
29. Kato T, Kunugi H, et al. 2000. Association of bipolar disorder with the 5178 polymorphism in mitochondrial DNA. Am J Med Genet 96:182-186. (Pubitemid 30180860)
30. Kato T, Kunugi H, et al. 2001. Mitochondrial DNA polymorphisms in bipolar disorder. J Affect Disord 62:151-164. (Pubitemid 32167082)
31. Kato T, Stine OC, et al. 1997. Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder. Biol Psychiatry 42:871-875.
32. Kaufmann P, Engelstad K, et al. 2009. Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol 66:85-91.
33. Kazuno AA, Munakata K, et al. 2005. Mitochondrial DNA sequence analysis of patients with 'atypical psychosis'. Psychiatry Clin Neurosci 59:497-503.
34. Kegeles LS, Humaran TJ, et al. 1998. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Biol Psychiatry 44:382-398.
35. Kiejna A, DiMauro S, et al. 2002. Psychiatric symptoms in a patient with the clinical features of MELAS. Med Sci Monit 8: CS66-CS72.
36. Kirk R, Furlong RA, et al. 1999. Mitochondrial genetic analyses suggest selection against maternal lineages in bipolar affective disorder. Am J Hum Genet 65:508-518. (Pubitemid 30463008)
37. Konradi C, Eaton M, et al. 2004. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61:300-308.
38. Kung L, Roberts RC. 1999. Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse 31:67-75. (Pubitemid 29009281)
39. Laruelle M, Abi-Dargham A, et al. 1999. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46:56-72.
40. Lindholm E, Cavelier L, et al. 1997. Mitochondrial sequence variants in patients with schizophrenia. Eur J Hum Genet 5:406-412.
41. Luoma P, Melberg A, et al. 2004. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364:875-882.
42. MacDonald ML, Naydenov A, et al. 2006. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord 8:255-264.
43. Mahadik SP, Scheffer RE. 1996. Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 55:45-54.
44. Mancuso M, Filosto M, et al. 2004. POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy, ataxia, and deafness. Neurology 62:316-318. (Pubitemid 38167151)
45. Marchbanks RM, Ryan M, et al. 2003. A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr Res 65:33-38.
46. Martorell L, Segues T, et al. 2006. New variants in the mitochondrial genomes of schizophrenic patients. Eur J Hum Genet 14:520-528.
47. McMahon FJ, Chen YS, et al. 2000. Mitochondrial DNA sequence diversity in bipolar affective disorder. Am J Psychiatry 157:1058-1064. (Pubitemid 30432484)
48. McMahon FJ, Stine OC, et al. 1995. Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet 56:1277-1286.
49. Mexal S, Berger R, et al. 2006. Brain pH has a significant impact on human postmortem hippocampal gene expression profiles. Brain Res 1106:1-11.
50. Middleton FA, Mirnics K, et al. 2002. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22:2718-2729.
51. Miyaoka H, Suzuki Y, et al. 1997. Mental disorders in diabetic patients with mitochondrial transfer RNA(Leu) (UUR) mutation at position 3243. Biol Psychiatry 42:524-526. (Pubitemid 27394622)
52. Mulcrone J, Whatley SA, et al. 1995. A study of altered gene expression in frontal cortex from schizophrenic patients using differential screening. Schizophr Res 14:203-213.
53. Munakata K, Fujii K, et al. 2007. Sequence and functional analyses of mtDNA in a maternally inherited family with bipolar disorder and depression. Mutat Res 617:119-124.
54. Munakata K, Iwamoto K, et al. 2005. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol Psychiatry 57:525-532. (Pubitemid 40311988)
55. Munakata K, Tanaka M, et al. 2004. Mitochondrial DNA 3644T>C mutation associated with bipolar disorder. Genomics 84: 1041-1050.
56. Odawara M, Arinami T, et al. 1998. Absence of association between a mitochondrial DNA mutation at nucleotide position 3243 and schizophrenia in Japanese. Hum Genet 102:708-709. (Pubitemid 28362770)
57. Onishi H, Kawanishi C, et al. 1997. Depressive disorder due to mitochondrial transfer RNALeu(UUR) mutation. Biol Psychiatry 41:1137-1139.
58. Pachalska M, DiMauro S, et al. 2001. Pathomechanism and clinical presentation of neurobehavioral disturbances in a patient with MELAS syndrome. Neurol Neurochir Pol 35:681-693.
59. Perez J, Tardito D, et al. 2000. Abnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment. Bipolar Disord 2:27-36.
60. Prabakaran S, Swatton JE, et al. 2004. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9:643,684-697. (Pubitemid 38932173)
61. Prayson RA, Wang N. 1998. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) syndrome: an autopsy report. Arch Pathol Lab Med 122:978-981. (Pubitemid 28521044)
62. Prince JA, Blennow K, et al. 1999. Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology 21:372-379.
63. Prince JA, Yassin MS, et al. 1997. Neuroleptic-induced mitochondrial enzyme alterations in the rat brain. J Pharmacol Exp Ther 280:261-267. (Pubitemid 27171411)
64. Sabunciyan S, Kirches E, et al. 2007. Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder. J Neural Transm 114:665-674.
65. Shao L, Martin MV, et al. 2008. Mitochondrial involvement in psychiatric disorders. Ann Med 40:281-295.
66. Shimizu A, Kurachi M, et al. 1987. Morbidity risk of schizophrenia to parents and siblings of schizophrenic patients. Jpn J Psychiatry Neurol 41:65-70. (Pubitemid 17114718)
67. Siciliano G, Tessa A, et al. 2003. Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANT1 gene. Neuromuscul Disord 13:162-165.
68. Silverstone PH, Wu RH, et al. 2003. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol 18:73-79.
69. Simpson PB, Russell JT. 1998. Role of mitochondrial Ca2+ regulation in neuronal and glial cell signalling. Brain Res Brain Res Rev 26:72-81.
70. Smythies J. 1999. Redox mechanisms at the glutamate synapse and their significance: a review. Eur J Pharmacol 370:1-7. (Pubitemid 29168509)
71. Soares JC, Mallinger AG. 1997. Intracellular phosphatidylinositol pathway abnormalities in bipolar disorder patients. Psychopharmacol Bull 33:685-691.
72. Sohm B, Frugier M, et al. 2003. Towards understanding human mitochondrial leucine aminoacylation identity. J Mol Biol 328:995-1010.
73. Sohm B, Sissler M, et al. 2004. Recognition of human mitochondrial tRNALeu(UUR) by its cognate leucyl-tRNA synthetase. J Mol Biol 339:17-29.
74. Sokolov BP, Jiang L, et al. 2003. Transcription profiling reveals mitochondrial, ubiquitin and signaling systems abnormalities in post-mortem brains from subjects with a history of alcohol abuse or dependence. J Neurosci Res 72:756-767.
75. Spelbrink JN, Li FY, et al. 2001. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 28:223-231.
76. Stine OC, Luu SU, et al. 1993. The possible association between affective disorder and partially deleted mitochondrial DNA. Biol Psychiatry 33:141-142. (Pubitemid 23069202)
77. Stork C, Renshaw PF. 2005. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 10:900-919.
78. Strakowski SM, DelBello MP, et al. 2000. Neuroimaging in bipolar disorder. Bipolar Disord 2:148-164.
79. Sun X, Wang JF, et al. 2006. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci 31:189-196.
80. Suomalainen A, Majander A, et al. 1992. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest 90:61-66.
81. Suzuki Y, Taniyama M, et al. 1997. Diabetes mellitus associated with 3243 mitochondrial tRNA(Leu(UUR)) mutation: clinical features and coenzyme Q10 treatment. Mol Aspects Med 18 Suppl:S181-S188.
82. Thomeer EC, Verhoeven WM, et al. 1998. Psychiatric symptoms in MELAS; a case report. J Neurol Neurosurg Psychiatry 64:692-693.
83. Ueda Y, Ando A, et al. 2004. A boy with mitochondrial disease: asymptomatic proteinuria without neuromyopathy. Pediatr Nephrol 19:107-110. (Pubitemid 38088261)
84. Uranova N, Orlovskaya D, et al. 2001. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull 55:597-610.
85. Van Goethem G, Dermaut B, et al. 2001. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28:211-212.
86. Van Goethem G, Lofgren A, et al. 2003. Digenic progressive external ophthalmoplegia in a sporadic patient: recessive mutations in POLG and C10orf2/Twinkle. Hum Mutat 22:175-176. (Pubitemid 36950817)
87. Vawter MP, Tomita H, et al. 2006. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry 11:615, 663-679.
88. Videbech P. 2000. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand 101:11-20. (Pubitemid 30041119)
89. Volz HR, Riehemann S, et al. 2000. Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study. Biol Psychiatry 47:954-961.
90. Volz HP, Rzanny R, et al. 1997. 31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique - preliminary findings. Biol Psychiatry 41:644-648. (Pubitemid 27157755)
91. Wallace DC, Ye JH, et al. 1987. Sequence analysis of cDNAs for the human and bovine ATP synthase beta subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet 12:81-90.
92. Wang JF, Shao L, et al. 2004. Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons. J Neurochem 88:1477-1484.
93. Washizuka S, Iwamoto K, et al. 2004. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder in Japanese and the National Institute of Mental Health pedigrees. Biol Psychiatry 56:483-489.
94. Whatley SA, Curti D, et al. 1998. Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients. Mol Psychiatry 3:227-237. (Pubitemid 28266332)
95. Winokur G, Reich T. 1970. Two genetic factors in manic-depressive disease. Compr Psychiatry 11:93-99.
96. Wolyniec PS, Pulver AE, et al. 1992. Schizophrenia: gender and familial risk. J Psychiatr Res 26:17-27.
97. Yamawaki S, Kagaya A, et al. 1998. Intracellular calcium signaling systems in the pathophysiology of affective disorders. Life Sci 62:1665-1670.
98. Yamazaki M, Igarashi H, et al. 1991. A case of mitochondrial encephalomyopathy with schizophrenic psychosis, dementia and neuroleptic malignant syndrome. Rinsho Shinkeigaku 31:1219-1223.
99. Yang J, Visscher PM, et al. 2009. Sporadic cases are the norm for complex disease. Eur J Hum Genet. DOI: 10.1038/ejhg.2009.177.
100. Zarate CA Jr, Singh J, et al. 2006. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 59:1006-1020.